STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,000 | -60.0% | 2,914 | -64.0% | 0.00% | – |
| Q4 2020 | $20,000 | +400.0% | 8,100 | +374.5% | 0.00% | – |
| Q3 2020 | $4,000 | -78.9% | 1,707 | -66.1% | 0.00% | – |
| Q2 2020 | $19,000 | -5.0% | 5,040 | -51.2% | 0.00% | – |
| Q1 2020 | $20,000 | +33.3% | 10,329 | +42.1% | 0.00% | – |
| Q4 2019 | $15,000 | +200.0% | 7,267 | +211.5% | 0.00% | – |
| Q3 2019 | $5,000 | -84.8% | 2,333 | -77.8% | 0.00% | – |
| Q2 2019 | $33,000 | +725.0% | 10,501 | +1172.8% | 0.00% | – |
| Q1 2019 | $4,000 | -97.8% | 825 | -97.3% | 0.00% | – |
| Q2 2018 | $183,000 | +471.9% | 30,502 | +725.9% | 0.00% | – |
| Q1 2018 | $32,000 | +128.6% | 3,693 | +104.7% | 0.00% | – |
| Q4 2017 | $14,000 | – | 1,804 | +2552.9% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 68 | -99.9% | 0.00% | – |
| Q2 2017 | $338,000 | – | 47,241 | +944720.0% | 0.00% | – |
| Q1 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |